420 with CNW — Analysis of Differences Between Taxes on

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
236
420 with CNW — Analysis of Differences Between Taxes on Marijuana, Sports Betting

In 2021, Arizona witnessed the legalization of two long-operating but previously illicit industries: sports betting and recreational cannabis. This change brought a surge of tax revenue to the state, with one industry outpacing the other significantly.

While sports betting enjoys greater popularity per capita in the state, it contributes only a small percentage of the taxes compared to the marijuana sector.

According to 2023 revenue data, the total wagering amount on sportsbooks in the state was almost five times greater than the state’s entire marijuana sales. However, despite this, the tax revenue from cannabis companies was more than eight times higher than that from sports betting.

According to the state’s Gaming Department, more than $6.5 billion was collected through sportsbooks and betting apps in 2023. However, sports betting companies paid somewhat more than $34.8 million to the state treasury, which was placed in the general fund. In contrast, the state’s Revenue Department reported that retail marijuana sales, encompassing both recreational and medical sales, amounted to about $1.36 billion in the same period, with tax collected from these sales being $284.3 million.

The disparity in tax rates between the two sectors can be attributed to the distinct regulatory frameworks governing them. The marijuana market bears a heavy tax burden, with several levies imposed on every sale. Marijuana dispensaries in the state are required to report sales for both recreational and medical purposes. Additionally, besides the standard sales tax, dispensaries are subject to a 16% state excise tax. Revenues generated from this tax are allocated to various sectors including public safety and community colleges.

On the other hand, laws governing sports betting in the state stipulate that taxes are paid on net revenue following payouts to successful bettors rather than the whole amount wagered. As a result, the state receives less tax money from larger reimbursements. Moreover, sportsbooks can deduct expenses such as promotional offers and free bets from their gross revenue, further reducing the taxable amount. Last year, more than $196 million in free bets were distributed by sportsbooks in Arizona, diminishing potential tax revenue by almost $20 million.

Compared to other states that have legalized sports betting, Arizona levies a lower 10% tax on gross wagering earnings from operators. Massachusetts taxes sportsbook profits at 20%, whereas Illinois taxes them at 15%. The tax rates in New Hampshire, Rhode Island and New York are notably higher, at 51%.

While it is possible to make changes to the current statutes, doing so may be difficult because neither was created by the state’s legislature. Recreational cannabis was legalized through a ballot vote in 2020, while sports betting was approved via a renegotiated gaming agreement between Arizona’s state government and native American tribes.

The Arizona marijuana community has expressed concerns about the excessive tax loads in comparison to the sports betting sector.

Mazor Collective CEO Lilach Mazor Power expressed frustration, highlighting the perceived greater social value of the marijuana industry. Mazor Power stated that the sports betting sector may potentially do more. She also stressed that not everyone involved in the marijuana industry makes significant money, so it’s important to be wary of assuming that everyone is wealthy.

Representatives of the gaming sector, on the other hand, state that even with its widespread appeal, sports betting only generates marginal returns when contrasted with other gaming options, such as slot machines or board games.

When the excessive taxes to which the marijuana industry is subjected reach untenable levels, there could be a domino effect that could result in reduced business opportunities for ancillary companies, such as Astrotech Corp. (NASDAQ: ASTC), that serve verticals within the cannabis industry.

NOTE TO INVESTORS: The latest news and updates relating to Astrotech Corp. (NASDAQ: ASTC) are available in the company’s newsroom at https://ibn.fm/ASTC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer


Astrotech Corp. (ASTC) Stock Research Links

ASTC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Strengthening User Protection in Cryptocurrency Trading

Updated Category News Views 189

Goldenes Intelligentes Münzhandelszentrum Enhances Trading Security Goldenes Intelligentes Münzhandelszentrum has unveiled a significant upgrade to its global user protection framework, positioning itself and its users ahead in the competitive landscape of crypto derivatives exchange. Enhanced Security Features This upgrade addresses increasing cybersecurity threats and...

Continue Reading
Upcoming Earnings: What to Expect from PPG Industries

Updated Category News Views 100

Anticipating the PPG Industries Earnings Report PPG Industries (PPG) is gearing up for its next quarterly earnings announcement, creating buzz among investors eager for insights into its financial performance. The anticipated date for this announcement is fast approaching, sparking interest and speculation. Analysts have set expectations, projecting that PPG Industries...

Continue Reading
Join the Class Action for Reckitt Benckiser Shareholders Now

Updated Category News Views 149

Understanding the Class Action for Reckitt Benckiser Shareholders Attention shareholders of Reckitt Benckiser Group plc (RBGLY). If you purchased shares during the specified class period, there is an important opportunity to join a class action. This notice is particularly pertinent for those who may have suffered losses due to the company's alleged misleading statements...

Continue Reading
Craig Gentry Strengthens Cornami's Encryption Innovations

Updated Category News Views 122

Craig Gentry Joins Cornami, Boosting Cryptographic Expertise Cornami, a company dedicated to innovative computing solutions, has appointed Dr. Craig Gentry as their Chief Scientist for Algorithms. With Dr. Gentry's impressive background in cryptography, Cornami aims to enhance its vision of providing real-time encrypted computing capabilities. About Dr. Craig Gentry: A...

Continue Reading
ICG Enterprise Trust Executes Strategic Share Buyback Initiative

Updated Category News Views 172

ICG Enterprise Trust Ongoing Commitment to Shareholder Value ICG Enterprise Trust plc has recently taken a notable step in its commitment to maximizing shareholder value. On November 19, 2024, the company initiated a buyback of 10,000 of its own shares, a strategic move aimed at optimizing its share structure. Details of the Share Buyback The shares were repurchased at an...

Continue Reading